Prevalence and factors associated with tuberculosis infection among new school entrants, New York City, 1991-1993

International Journal of Tuberculosis and Lung Disease

Volumn 3, Issue 1, 1999, Pages 31-41

  Scholten, J N ^b   Fujiwara, Paula I ^a,b   Frieden, T R ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Box 74 ^*

Author keywords

Annual risk of infection; BCG vaccination; School children; Tuberculin skin testing; Tuberculosis

Indexed keywords

BCG VACCINE;

ADOLESCENT; ARTICLE; BCG VACCINATION; CHILD; FEMALE; HIGH RISK POPULATION; HIGH SCHOOL; HUMAN; HUMAN TISSUE; IMMIGRANT; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIMARY SCHOOL; PRIORITY JOURNAL; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOSIS CONTROL;

ADOLESCENT; BCG VACCINE; CHILD; CHILD, PRESCHOOL; EMIGRATION AND IMMIGRATION; FEMALE; HUMANS; MALE; MASS SCREENING; NEW YORK CITY; PREVALENCE; RISK FACTORS; SCHOOLS; TUBERCULIN TEST; TUBERCULOSIS;

EID: 0032979869     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. New York City Department of Health. Tuberculosis in children. City Health Information (CHI) 1990; 9: 1-3.
2. Brudney K, Dobkin J. Resurgent tuberculosis in New York City: human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. Am Rev Respir Dis 1991; 144: 745-749.
3. Dolin P J, Raviglione M C, Kochi A. Review of current epidemiological data and estimation of future tuberculosis incidence and mortality. World Health Organization 1993; 173: 1-34.
4. Mandatory Tuberculosis Examination, Hearing on New York City Health Code 49.06 before New York City Board of Health (June 20, 1989).
5. Snider D E, Anderson H R, Bentley S E. Current tuberculosis screening practices. Am J Public Health 1984; 74: 1353-1356.
6. Davidson P T, Ashkar B, Salem N. Tuberculosis testing of children entering school in Los Angeles County, California [abstract]. Am Rev Respir Dis 1990; 141: A336.
7. Barry M A, Shirley L, Grady M T, et al. Tuberculosis infection in urban adolescents: results of a school-based testing program. Am J Public Health 1990; 80: 439-441.
8. Driver C R, Valway S E, Cantwell M F, et al. Tuberculin skin test screening in schoolchildren in the United States. Pediatrics 1996; 98: 97-102.
9. Comstock G W, Edwards L B, Nabangxang H. Tuberculin sensitivity eight to fifteen years after BCG Vaccination. Am Rev Respir Dis 1971; 103: 572-575.
10. Sepulveda R L, Constanza B, Ferrer X, et al. Booster effect of tuberculin testing in healthy 6-year-old school children vaccinated with Bacillus Calmette-Guérin at birth in Santiago, Chile. Pediatr Infect Dis J 1988; 7: 578-581.
11. Menzies R, Vissandjee B. Effect of bacille Calmette-Guérin vaccination on tuberculin reactivity. Am Rev Respir Dis 1992; 145: 621-625.
12. Miret-Cuadras P, Pina-Gutierrez J M, Juncosa S. Tuberculin reactivity in bacillus Calmette-Guérin vaccinated subjects. Tubercle Lung Dis 1996; 77: 52-58.
13. Styblo K. Epidemiology of tuberculosis: selected papers. The Hague. Royal Netherlands Tuberculosis Association; 1991 (24).
14. Sudre P, Ten Dam G, Kochi A. Tuberculosis: a global overview of the situation today. Bull WHO 1992; 70: 149-159.
15. Bass J B Jr. Tuberculin skin test. In: Reichman L B, Hershfield E S, eds. Tuberculosis: a comprehensive international approach. New York, Marcel Dekker, 1993: 139-148.
16. United States Department of Commerce. US Census. Washington, DC; Bureau of Census, 1990.
17. O'Brien R. BCG Vaccination Coverage. Geneva, Switzerland: WHO. Global Tuberculosis Programme-Research and Surveillance Unit: 1996 Jan Request Ref. TRS.
18. SAS Institute, Inc. Mainframe version. Cary, NC; 1989.
19. Epi Info, version 6.02. Atlanta, GA: CDC, 1994.
20. Styblo K, Meijer J, Sutherland I. Transmission of tubercle bacilli: its trend in a human population. Bull Int Union Tuberc 1969; 42: 5-104.
21. Rieder H L. Methodological issues in the estimation of the tuberculosis problem from tuberculin surveys. Tubercle Lung Dis 1995; 76: 114-121.
22. Guld J, Waaler H, Sundaresan T K, et al. Duration of BCG-induced tuberculin sensitivity in children, and its irrelevance for revaccination. Bull World Health Organ 1968; 39: 829-836.
23. Department of City Planning. City of New York. Demographic profiles. August 1992.
24. Edwards L B, Acquaviva F A, Livesay V T. Identification of tuberculous infected: dual tests and density of reaction. Am Rev Respir Dis 1973; 108: 1334-1339.
25. Trump D H, Hyams K C, Cross E R, Struewing J P. Tuberculosis infection among young adults entering the US navy in 1990. Arch Intern Med 1993; 153: 211-216.
26. Comstock G W. A comparison of purified tuberculins in the southeastern USA. Bull World Health Organ 1960; 23: 683-688.
27. Lifschitz M. Value of the TST as a screening test for tuberculosis among BCG-vaccinated children. Pediatrics 1965; 36: 624-627.
28. Horwitz O, Bunch-Christensen K. Correlation between tuberculin sensitivity after 2 months and 5 years among BCG vaccinated subjects. Bull World Health Organ 1972; 47: 49-58.
29. Raviglione M C, Rieder H E, Styblo K, Khomenko A G, Esteves K, Kochi A. Tuberculosis trends in Eastern Europe and the former USSR. Tubercle Lung Dis 1994; 75: 400-416.
30. Snider D E Jr, Cauthen G M. Tuberculin skin testing of hospital employees: infection, boosting, and two-step testing. Am J Infect Control 1994; 12: 305-311.
31. Landi S, Ashley M J, Grzybowski S. Tuberculin sensitivity following the intradermal and multiple puncture methods of BCG vaccination. Can Med Assoc J 1967; 97: 222-225.
32. Snider D E. Bacille Calmette-Guérin vaccinations and tuberculin skin tests. JAMA 1985; 253: 3438-3439.
33. American Thoracic Society. Diagnostic standards and classification of tuberculosis. Am Rev Respir Dis 1990; 142: 725-735.
34. Sass P, Cooper K, Robertson V. School-based tuberculosis testing and treatment program comparing directly observed preventive therapy with traditional preventive therapy. Journal of Public Health Management and Practice 1996; 2: 32-40.
35. Adhikari N, Menzies R. Community-based tuberculin screening in Montreal: a cost-outcome description. Am J Public Health 1995; 85: 786-790.
36. Mohle-Boetani J, Miller B, Halpern M, et al. School-based screening for tuberculosis infection: a cost-benefit analysis. JAMA 1995; 274: 613-619.
37. New York City Department of Health. Recommendations on prevention and control of pediatric tuberculosis in New York City: expert advisory panel. New York, 1995.
38. Centers for Disease Control and Prevention. Screening for tuberculosis and tuberculosis infection in high-risk populations. MMWR 1995; 44: 19-34.
39. American Academy of Pediatrics Committee on Infectious Diseases. Screening of infants and children. Pediatrics 1994; 93: 131-134.
40. Centers for Disease Control and Prevention. Purified protein derivative (PPD)-tuberculin anergy and HIV infection: guidelines for anergy testing and management of anergic persons at risk of tuberculosis. MMWR 1991; 40: 27-33.
41. Huebner R E, Schein M F, Bass J B. The tuberculin skin test. Clin Infect Dis 1993; 17: 968-975.
42. Snider D E. The tuberculin skin test. Am Rev Respir Dis 1982; 125: 108-118.